1. Cyanocobalamin is already an approved drug for the treatment of anemia.
Will this be a future indication? Pill vs Shot
2. Conclude a distribution agreement for US and support that marketing launch.
This was not on your list of goals over the next 12-18 months, should it be?
3. Have trials been executed with smaller dosages? If so I imagine they where not as effective as this dosage.
My guess is that interested investors are on the side lines until the financing plans are complete. No one wants to buy a stock at $2 and see a financing a week later at $1.50. Then again no one wants to be on the side lines when a major partnership is announced.